Cargando…
Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil
BACKGROUND: Sickle cell disease (SCD) is a fatal monogenic disorder with no effective cure and thus high rates of morbidity and sequelae. Efforts toward discovery of disease modifying drugs and curative strategies can be augmented by leveraging the plethora of information contained in available biom...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677893/ https://www.ncbi.nlm.nih.gov/pubmed/23762313 http://dx.doi.org/10.1371/journal.pone.0065190 |
_version_ | 1782272772491182080 |
---|---|
author | Essack, Magbubah Radovanovic, Aleksandar Bajic, Vladimir B. |
author_facet | Essack, Magbubah Radovanovic, Aleksandar Bajic, Vladimir B. |
author_sort | Essack, Magbubah |
collection | PubMed |
description | BACKGROUND: Sickle cell disease (SCD) is a fatal monogenic disorder with no effective cure and thus high rates of morbidity and sequelae. Efforts toward discovery of disease modifying drugs and curative strategies can be augmented by leveraging the plethora of information contained in available biomedical literature. To facilitate research in this direction we have developed a resource, Dragon Exploration System for Sickle Cell Disease (DESSCD) (http://cbrc.kaust.edu.sa/desscd/) that aims to promote the easy exploration of SCD-related data. DESCRIPTION: The Dragon Exploration System (DES), developed based on text mining and complemented by data mining, processed 419,612 MEDLINE abstracts retrieved from a PubMed query using SCD-related keywords. The processed SCD-related data has been made available via the DESSCD web query interface that enables: a/information retrieval using specified concepts, keywords and phrases, and b/the generation of inferred association networks and hypotheses. The usefulness of the system is demonstrated by: a/reproducing a known scientific fact, the “Sickle_Cell_Anemia–Hydroxyurea” association, and b/generating novel and plausible “Sickle_Cell_Anemia–Hydroxyfasudil” hypothesis. A PCT patent (PCT/US12/55042) has been filed for the latter drug repurposing for SCD treatment. CONCLUSION: We developed the DESSCD resource dedicated to exploration of text-mined and data-mined information about SCD. No similar SCD-related resource exists. Thus, we anticipate that DESSCD will serve as a valuable tool for physicians and researchers interested in SCD. |
format | Online Article Text |
id | pubmed-3677893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36778932013-06-12 Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil Essack, Magbubah Radovanovic, Aleksandar Bajic, Vladimir B. PLoS One Research Article BACKGROUND: Sickle cell disease (SCD) is a fatal monogenic disorder with no effective cure and thus high rates of morbidity and sequelae. Efforts toward discovery of disease modifying drugs and curative strategies can be augmented by leveraging the plethora of information contained in available biomedical literature. To facilitate research in this direction we have developed a resource, Dragon Exploration System for Sickle Cell Disease (DESSCD) (http://cbrc.kaust.edu.sa/desscd/) that aims to promote the easy exploration of SCD-related data. DESCRIPTION: The Dragon Exploration System (DES), developed based on text mining and complemented by data mining, processed 419,612 MEDLINE abstracts retrieved from a PubMed query using SCD-related keywords. The processed SCD-related data has been made available via the DESSCD web query interface that enables: a/information retrieval using specified concepts, keywords and phrases, and b/the generation of inferred association networks and hypotheses. The usefulness of the system is demonstrated by: a/reproducing a known scientific fact, the “Sickle_Cell_Anemia–Hydroxyurea” association, and b/generating novel and plausible “Sickle_Cell_Anemia–Hydroxyfasudil” hypothesis. A PCT patent (PCT/US12/55042) has been filed for the latter drug repurposing for SCD treatment. CONCLUSION: We developed the DESSCD resource dedicated to exploration of text-mined and data-mined information about SCD. No similar SCD-related resource exists. Thus, we anticipate that DESSCD will serve as a valuable tool for physicians and researchers interested in SCD. Public Library of Science 2013-06-10 /pmc/articles/PMC3677893/ /pubmed/23762313 http://dx.doi.org/10.1371/journal.pone.0065190 Text en © 2013 Essack et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Essack, Magbubah Radovanovic, Aleksandar Bajic, Vladimir B. Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil |
title | Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil |
title_full | Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil |
title_fullStr | Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil |
title_full_unstemmed | Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil |
title_short | Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil |
title_sort | information exploration system for sickle cell disease and repurposing of hydroxyfasudil |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677893/ https://www.ncbi.nlm.nih.gov/pubmed/23762313 http://dx.doi.org/10.1371/journal.pone.0065190 |
work_keys_str_mv | AT essackmagbubah informationexplorationsystemforsicklecelldiseaseandrepurposingofhydroxyfasudil AT radovanovicaleksandar informationexplorationsystemforsicklecelldiseaseandrepurposingofhydroxyfasudil AT bajicvladimirb informationexplorationsystemforsicklecelldiseaseandrepurposingofhydroxyfasudil |